Tumor-associated macrophages in glioma: Friend or foe?

Journal of Oncology

Volumn , Issue , 2013, Pages

  Kennedy, Benjamin C ^a   Showers, Christopher R ^a   Anderson, David E ^b   Anderson, Lisa ^b   Canoll, Peter ^a   Bruce, Jeffrey N ^a   Anderson, Richard C E ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Erinyes Biotechnologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD163 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; SCAVENGER RECEPTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTE; BONE MARROW CELL; CELL FUNCTION; CELL POLARITY; GLIOMA; GLIOMA CELL; HUMAN; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MONOCYTE; PROTEIN EXPRESSION; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 84878712718     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2013/486912     Document Type: Review

References (86)

1. Ohgaki H., Kleihues P., Epidemiology and etiology of gliomas. Acta Neuropathologica 2005 109 1 93 108 2-s2.0-14244265590 10.1007/s00401-005-0991-y (Pubitemid 40287792)
2. Holland E. C., Glioblastoma multiforme: the terminator. Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6242 6244 2-s2.0-0034612289 10.1073/pnas.97.12.6242 (Pubitemid 30412695)
3. Choi B. D., Chen K. S., Sampson J. H., Hayat M. A., Tumors of the central nervous system. Tumors of the Central Nervous System 2011 1 Dordrecht, The Netherlands Springer
4. Fabry Z., Raine C. S., Hart M. N., Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunology Today 1994 15 5 218 224 2-s2.0-0028217047 10.1016/0167-5699(94)90247-X (Pubitemid 24137975)
5. Harling-Berg C. J., Hallett J. J., Park J. T., Knopf P. M., Hierarchy of immune responses to antigen in the normal brain. Current Topics in Microbiology and Immunology 2002 265 1 22 2-s2.0-0036129750 (Pubitemid 34241976)
6. Gehrmann J., Banati R. B., Wiessner C., Hossmann K. A., Kreutzberg G. W., Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathology and Applied Neurobiology 1995 21 4 277 289 2-s2.0-0029157454
7. Hickey W. F., Kimura H., Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988 239 4837 290 292 2-s2.0-0023949553 (Pubitemid 18061496)
8. Beschorner R., Nguyen T. D., Gözalan F., Pedal I., Mattern R., Schluesener H. J., Meyermann R., Schwab J. M., CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathologica 2002 103 6 541 549 2-s2.0-0036939246 10.1007/s00401-001-0503-7 (Pubitemid 36067501)
9. Owens T., Renno T., Taupin V., Krakowski M., Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunology Today 1994 15 12 566 571 2-s2.0-0028029946 10.1016/0167-5699(94)90218-6 (Pubitemid 24353907)
10. Ulvestad E., Williams K., Bjerkvig R., Tiekotter K., Antel J., Matre R., Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. Journal of Leukocyte Biology 1994 56 6 732 740 2-s2.0-0028558519
11. Williams K. Jr., Ulvestad E., Cragg L., Blain M., Antel J. P., Induction of primary T cell responses by human glial cells. Journal of Neuroscience Research 1993 36 4 382 390 2-s2.0-0027482710 10.1002/jnr.490360404 (Pubitemid 23326318)
12. Miescher S., Whiteside T. L., de Tribolet N., von Fliedner V., In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. Journal of Neurosurgery 1988 68 3 438 448 2-s2.0-0023841573 (Pubitemid 18067645)
13. Heimberger A. B., Sampson J. H., Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma? Neuro-Oncology 2011 13 1 3 13 2-s2.0-79951641692 10.1093/neuonc/noq169
14. Small E. J., Schellhammer P. F., Higano C. S., Redfern C. H., Nemunaitis J. J., Valone F. H., Verjee S. S., Jones L. A., Hershberg R. M., Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. Journal of Clinical Oncology 2006 24 19 3089 3094 2-s2.0-33746012881 10.1200/JCO.2005.04.5252 (Pubitemid 46638945)
15. Hodi F. S., O'Day S. J., McDermott D. F., Improved survival with ipilimumab in patients with metastatic melanoma. The New England Journal of Medicine 2010 363 8 711 723 10.1056/NEJMoa1003466
16. Yamanaka R., Cell- and peptide-based immunotherapeutic approaches for glioma. Trends in Molecular Medicine 2008 14 5 228 235 2-s2.0-42749088763 10.1016/j.molmed.2008.03.003
17. Kuppner M. C., Hamou M. F., de Tribolet N., Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. Cancer Research 1988 48 23 6926 6932 2-s2.0-0024212342 (Pubitemid 19012228)
18. Mitchell D. A., Fecci P. E., Sampson J. H., Immunotherapy of malignant brain tumors. Immunological Reviews 2008 222 1 70 100 2-s2.0-41149117162 10.1111/j.1600-065X.2008.00603.x (Pubitemid 351430365)
19. Badie B., Schartner J., Role of microglia in glioma biology. Microscopy Research and Technique 2001 54 2 106 113 2-s2.0-0035879509 10.1002/jemt.1125 (Pubitemid 32645875)
20. Kostianovsky A. M., Maier L. M., Anderson R. C., Bruce J. N., Anderson D. E., Astrocytic regulation of human monocytic/microglial activation. Journal of Immunology 2008 181 8 5425 5432
21. Kennedy B. C., Maie L. M., 'Amico R. D., Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunology 2009 10 article 11 10.1186/1471-2172-10-11
22. Markovic D. S., Glass R., Synowitz M., van Rooijen N., Kettenmann H., Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. Journal of Neuropathology and Experimental Neurology 2005 64 9 754 762 2-s2.0-24644490056 (Pubitemid 41285807)
23. Watters J. J., Schartner J. M., Badie B., Microglia function in brain tumors. Journal of Neuroscience Research 2005 81 3 447 455 2-s2.0-25444488717 10.1002/jnr.20485 (Pubitemid 41359299)
24. Zhai H., Heppner F. L., Tsirka S. E., Microglia/macrophages promote glioma progression. Glia 2011 59 3 472 485 2-s2.0-78751700548 10.1002/glia.21117
25. Daginakatte G. C., Gutmann D. H., Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Human Molecular Genetics 2007 16 9 1098 1112 2-s2.0-34447320760 10.1093/hmg/ddm059 (Pubitemid 47062730)
26. Wesolowska A., Kwiatkowska A., Slomnicki L., Dembinski M., Master A., Sliwa M., Franciszkiewicz K., Chouaib S., Kaminska B., Microglia-derived TGF- β as an important regulator of glioblastoma invasion-an inhibition of TGF- β -dependent effects by shRNA against human TGF- β type II receptor. Oncogene 2008 27 7 918 930 2-s2.0-38949165993 10.1038/sj.onc.1210683 (Pubitemid 351225378)
27. Wagner S., Czub S., Greif M., Vince G. H., Süss N., Kerkau S., Rieckmann P., Roggendorf W., Roosen K., Tonn J. C., Microglial/macrophage expression of interleukin 10 in human glioblastomas. International Journal of Cancer 1999 82 1 12 16 (Pubitemid 29266099)
28. Penfield W., Microglia and the process of phagocytosis in gliomas. The American Journal of Pathology 1925 1 1 77 97
29. Li W., Graeber M. B., The molecular profile of microglia under the influence of glioma. Neuro-Oncology 2012 14 8 958 978 10.1093/neuonc/nos116
30. MacMicking J., Xie Q. W., Nathan C., Nitric oxide and macrophage function. Annual Review of Immunology 1997 15 323 350 2-s2.0-0030937832 10.1146/annurev.immunol.15.1.323 (Pubitemid 27169284)
31. Boehm U., Klamp T., Groot M., Howard J. C., Cellular responses to interferon-gamma. Annual Review of Immunology 1997 15 749 795 10.1146/annurev.immunol.15.1.749 (Pubitemid 27169298)
32. Hussain S. F., Yang D., Suki D., Grimm E., Heimberger A. B., Innate immune functions of microglia isolated from human glioma patients. Journal of Translational Medicine 2006 4 article 15 2-s2.0-33746096585 10.1186/1479-5876-4- 15 (Pubitemid 44069682)
33. Filipazzi P., Huber V., Rivoltini L., Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunology, Immunotherapy 2012 61 2 255 263 10.1007/s00262-011-1161-9
34. Huettner C., Czub S., Kerkau S., Roggendorf W., Tonn J. C., Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Research 1997 17 5 A 3217 3224 2-s2.0-0030778631 (Pubitemid 27522273)
35. Parney I. F., Basic concepts in glioma immunology. Advances in Experimental Medicine and Biology 2012 746 42 52 10.1007/978-1-4614-3146-6-4
36. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
37. Ling E. A., Wong W. C., The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 1993 7 1 9 18 2-s2.0-0027343619
38. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M. F., Conway S. J., Ng L. G., Stanley E. R., Samokhvalov I. M., Merad M., Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010 330 6005 841 845 2-s2.0-78149360132 10.1126/science.1194637
39. Morioka T., Baba T., Black K. L., Streit W. J., Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. Neurosurgery 1992 30 6 891 896 2-s2.0-0026784277
40. Morantz R. A., Wood G. W., Foster M., Clark M., Gollahon K., Macrophages in experimental and human brain tumors-part 2: studies of the macrophage content of human brain tumors. Journal of Neurosurgery 1979 50 3 305 311 2-s2.0-0018355350 (Pubitemid 9138066)
41. Lambertsen K. L., Clausen B. H., Babcock A. A., Gregersen R., Fenger C., Nielsen H. H., Haugaard L. S., Wirenfeldt M., Nielsen M., Dagnaes-Hansen F., Bluethmann H., Færgeman N. J., Meldgaard M., Deierborg T., Finsen B., Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. Journal of Neuroscience 2009 29 5 1319 1330 2-s2.0-59649117102 10.1523/JNEUROSCI.5505-08.2009
42. Priller J., Flügel A., Wehner T., Boentert M., Haas C. A., Prinz M., Fernández-Klett F., Prass K., Bechmann I., De Boer B. A., Frotscher M., Kreutzberg G. W., Persons D. A., Dirnagl U., Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nature Medicine 2001 7 12 1356 1361 2-s2.0-0035658031 10.1038/nm1201-1356 (Pubitemid 34007942)
43. Flgel A., Bradl M., Kreutzberg G. W., Graeber M. B., Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. Journal of Neuroscience Research 2001 66 1 74 82 2-s2.0-0035476293 10.1002/jnr.1198 (Pubitemid 32937060)
44. Rodriguez M., Alvarez-Erviti L., Blesa F. J., Rodríguez-Oroz M. C., Arina A., Melero I., Ramos L. I., Obeso J. A., Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Neurobiology of Disease 2007 28 3 316 325 2-s2.0-36148998691 10.1016/j.nbd.2007.07.024 (Pubitemid 350116601)
45. Simard A. R., Soulet D., Gowing G., Julien J. P., Rivest S., Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006 49 4 489 502 2-s2.0-32344440522 10.1016/j.neuron.2006.01.022 (Pubitemid 43221886)
46. AlShakweer W., Alwelaie Y., Mankung A. M., Graeber M. B., Bone marrow-derived microglia in pilocytic astrocytoma. Frontiers in Bioscience (Elite Edition) 2011 3 371 379 2-s2.0-79957875395
47. Badie B., Schartner J. M., Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 2000 46 4 957 962 2-s2.0-0034093158 (Pubitemid 30198803)
48. Germain D., Frank D. A., Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clinical Cancer Research 2007 13 19 5665 5669 2-s2.0-35348893870 10.1158/1078-0432.CCR-06-2491 (Pubitemid 47583890)
49. Rodrigues J. C., Gonzalez G. C., Zhang L., Ibrahim G., Kelly J. J., Gustafson M. P., Lin Y., Dietz A. B., Forsyth P. A., Yong V. W., Parney I. F., Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro-Oncology 2010 12 4 351 365 2-s2.0-77954641353 10.1093/neuonc/nop023
50. Schartner J. M., Hagar A. R., van Handel M., Zhang L., Nadkarni N., Badie B., Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 2005 51 4 279 285 2-s2.0-25444471021 10.1002/glia.20201 (Pubitemid 41532103)
51. Hirano T., Ishihara K., Hibi M., Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000 19 21 2548 2556 2-s2.0-0034658541 (Pubitemid 30339210)
52. Brantley E. C., Benveniste E. N., Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Molecular Cancer Research 2008 6 5 675 684 2-s2.0-51049123447 10.1158/1541-7786.MCR-07- 2180
53. Jansen T., Tyler B., Mankowski J. L., Recinos V. R., Pradilla G., Legnani F., Laterra J., Olivi A., FasL gene knock-down therapy enhances the antiglioma immune response. Neuro-Oncology 2010 12 5 482 489 2-s2.0-77954741566 10.1093/neuonc/nop052
54. Didenko V. V., Ngo H. N., Minchew C., Baskin D. S., Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism. Journal of Neurosurgery 2002 96 3 580 584 2-s2.0-0036125932 (Pubitemid 34230215)
55. Ford A. L., Foulcher E., Lemckert F. A., Sedgwick J. D., Microglia induce CD4 T lymphocyte final effector function and death. Journal of Experimental Medicine 1996 184 5 1737 1745 2-s2.0-0029848128 (Pubitemid 26404465)
56. Ford A. L., Foulcher E., Lemckert F. A., Sedgwick J. D., Microglia induce CD4T lymphocyte final effector function and death. Journal of Experimental Medicine 1996 184 5 1737 1745 10.1084/jem.184.5.1737 (Pubitemid 26404465)
57. Badie B., Schartner J., Prabakaran S., Paul J., Vorpahl J., Expression of Fas ligand by microglia: possible role in glioma immune evasion. Journal of Neuroimmunology 2001 120 1-2 19 24 2-s2.0-0034749035 10.1016/S0165-5728(01) 00361-7 (Pubitemid 33016720)
58. Wintterle S., Schreiner B., Mitsdoerffer M., Schneider D., Chen L., Meyermann R., Weller M., Wiendl H., Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Research 2003 63 21 7462 7467 (Pubitemid 37413489)
59. Parsa A. T., Waldron J. S., Panner A., Crane C. A., Parney I. F., Barry J. J., Cachola K. E., Murray J. C., Tihan T., Jensen M. C., Mischel P. S., Stokoe D., Pieper R. O., Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nature Medicine 2007 13 1 84 88 (Pubitemid 46067390)
60. Samuels V., Barrett J. M., Bockman S., Pantazis C. G., Allen M. B., Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. The American Journal of Pathology 1989 134 4 895 902 2-s2.0-0024654697 (Pubitemid 19111255)
61. Badie B., Schartner J., Klaver J., Vorpahl J., In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 1999 44 5 1077 1083 2-s2.0-0032931667 10.1097/00006123-199905000-00075 (Pubitemid 29202868)
62. Tsai J. C., Goldman C. K., Gillespie G. Y., Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. Journal of Neurosurgery 1995 82 5 864 873 2-s2.0-0028941001
63. Kjellman C., Olofsson S. P., Hansson O., von Schantz T., Lindvall M., Nilsson I., Salford L. G., Sjögren H. O., Widegren B., Expression of TGF- β isoforms, TGF- β receptors, and SMAD molecules at different stages of human glioma. International Journal of Cancer 2000 89 3 251 258 (Pubitemid 30430741)
64. Bodmer S., Strommer K., Frei K., Siepl C., de Tribolet N., Heid I., Fontana A., Immunosuppression and transforming growth factor- β in glioblastoma. Preferential production of transforming growth factor- β 2. Journal of Immunology 1989 143 10 3222 3229 2-s2.0-0024399070 (Pubitemid 20010149)
65. Wu A., Wei J., Kong L. Y., Wang Y., Priebe W., Qiao W., Sawaya R., Heimberger A. B., Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-Oncology 2010 12 11 1113 1125 2-s2.0-78049270536 10.1093/neuonc/noq082
66. Koochekpour S., Merzak A., Pilkington G. J., Vascular endothelial growth factor production is stimulated by gangliosides and TGF- β isoforms in human glioma cells in vitro. Cancer Letters 1996 102 1-2 209 215 2-s2.0-0029871064 10.1016/0304-3835(96)04161-4 (Pubitemid 26097822)
67. Wick W., Platten M., Weller M., Glioma cell invasion: regulation of metalloproteinase activity by TGF- β Journal of Neuro-Oncology 2001 53 2 177 185 2-s2.0-0034765067 10.1023/A:1012209518843 (Pubitemid 33034690)
68. Kiefer R., Gold R., Gehrmann J., Lindholm D., Wekerle H., Kreutzberg G. W., Transforming growth factor β expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. Journal of Neuroscience Research 1993 36 4 391 398 2-s2.0-0027423520 10.1002/jnr.490360405 (Pubitemid 23326319)
69. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H., Transforming growth factor- β 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. Journal of Cell Biology 1992 117 2 395 400 2-s2.0-0026510668 10.1083/jcb.117.2.395
70. Kiefer R., Supler M. L., Toyka K. V., Streit W. J., In situ detection of transforming growth factor- β mRNA in experimental rat glioma and reactive glial cells. Neuroscience Letters 1994 166 2 161 164 2-s2.0-0028006348 10.1016/0304-3940(94)90475-8 (Pubitemid 24053818)
71. Maher E. A., Furnari F. B., Bachoo R. M., Rowitch D. H., Louis D. N., Cavenee W. K., DePinho R. A., Malignant glioma: genetics and biology of a grave matter. Genes and Development 2001 15 11 1311 1333 2-s2.0-0034987702 10.1101/gad.891601 (Pubitemid 32524640)
72. Nolte C., Kirchhoff F., Kettenmann H., Epidermal growth factor is a motility factor for microglial cells in vitro: evidence for EGF receptor expression. European Journal of Neuroscience 1997 9 8 1690 1698 2-s2.0-0030802319 10.1111/j.1460-9568.1997.tb01526.x (Pubitemid 27348327)
73. Coniglio S. J., Eugenin E., Dobrenis K., Stanley E. R., West B. L., Symons M. H., Segall J. E., Microglial stimulation of glioblastoma invasion involves EGFR and CSF-1R signaling. Molecular Medicine 2012 18 519 527 10.2119/molmed.2011.00217
74. Koochekpour S., Jeffers M., Rulong S., Taylor G., Klineberg E., Hudson E. A., Resau J. H., Vande Woude G. F., Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Research 1997 57 23 5391 5398 2-s2.0-0030690583 (Pubitemid 27516379)
75. Kunkel P., Müller S., Schirmacher P., Stavrou D., Fillbrandt R., Westphal M., Lamszus K., Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro-Oncology 2001 3 2 82 88 2-s2.0-0035319502 10.1215/S1522851700000442 (Pubitemid 33691765)
76. Laterra J., Nam M., Rosen E., Rao J. S., Lamszus K., Goldberg I. D., Johnston P., Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Laboratory Investigation 1997 76 4 565 577 2-s2.0-0030975492 (Pubitemid 27176109)
77. Eckerich C., Zapf S., Fillbrandt R., Loges S., Westphal M., Lamszus K., Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. International Journal of Cancer 2007 121 2 276 283 2-s2.0-34250340883 10.1002/ijc.22679 (Pubitemid 46917695)
78. Sheng-Hua C., Yan-Bin M., Zhi-An Z., Hong Z., Dong-Fu F., Zhi-Qiang L., Xian-Hou Y., Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines. Surgical Neurology 2007 68 6 610 613 10.1016/j.surneu.2006. 12.050 (Pubitemid 350167462)
79. Waziri A., Killory B., Ogden A. T. III, Canoll P., Anderson R. C. E., Kent S. C., Anderson D. E., Bruce J. N., Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma. Journal of Immunology 2008 180 11 7673 7680 2-s2.0-47249086803
80. El Andaloussi A., Lesniak M. S., An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. Neuro-Oncology 2006 8 3 234 243 2-s2.0-33748481603 10.1215/15228517-2006-006 (Pubitemid 46542648)
81. Fecci P. E., Mitchell D. A., Whitesides J. F., Xie W., Friedman A. H., Archer G. E., Herndon J. E. II, Bigner D. D., Dranoff G., Sampson J. H., Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Research 2006 66 6 3294 3302 2-s2.0-33645502885 10.1158/0008-5472.CAN-05-3773
82. Ohgaki H., Kleihues P., The definition of primary and secondary glioblastoma. Clinical Cancer Research 2013 19 4 764 772 10.1158/1078-0432.CCR- 12-3002
83. Mizoguchi M., Betensky R. A., Batchelor T. T., Bernay D. C., Louis D. N., Nutt C. L., Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. Journal of Neuropathology and Experimental Neurology 2006 65 12 1181 1188 2-s2.0-33845370278 10.1097/01.jnen.0000248549.14962.b2 (Pubitemid 44885942)
84. Zhang L., Alizadeh D., van Handel M., Kortylewski M., Yu H., Badie B., Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia 2009 57 13 1458 1467 2-s2.0-70349097179 10.1002/glia.20863
85. Schaefer L. K., Menter D. G., Schaefer T. S., Activation of Stat3 and Stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines. Cellular Signalling 2000 12 3 143 151 2-s2.0-0034002463 10.1016/S0898-6568(99)00077-7 (Pubitemid 30126031)
86. Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., Niu G., Kay H., Mulé J., Kerr W. G., Jove R., Pardoll D., Yu H., Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nature Medicine 2005 11 12 1314 1321 2-s2.0-28644445445 10.1038/nm1325 (Pubitemid 41752912)